|
|
||||||||
Clinical Chemistry, Vol 38, 2244-2248, Copyright © 1992 by American Association for Clinical Chemistry
K Oida, H Takai, H Maeda, S Takahashi, A Shimada, J Suzuki, T Tamai, T Nakai and S Miyabo
Third Department of Internal Medicine, Fukui Medical School, Japan.
To investigate the relation between renal function and concentrations of lipoprotein(a) [Lp(a)] in serum, we measured Lp(a) in samples of serum and urine from patients with diabetes mellitus and in samples sent to a laboratory center for measurements of creatinine clearance. Serum Lp(a) concentrations were significantly increased in subjects with obvious renal dysfunction (serum creatinine > or = 176.8 mumol/L) compared with normal control subjects. Urinary Lp(a) excretion was decreased in subjects with obvious renal dysfunction compared with subjects without obvious renal dysfunction (serum creatinine < or = 88.4 mumol/L) and was negatively and positively correlated with serum creatinine and creatinine clearance, respectively. More than 80% of urinary Lp(a) was recovered in the d > 1.21 kg/L fraction. At least six bands for apolipoprotein(a) [apo(a)] fragments, which were smaller than native apo(a) in serum, were observed in urine by immunoblotting, and some of these were also detected in serum. Degraded apo(a) fragments are probably present in urine, and their excretion decreases in parallel with decreases in the glomerular filtration rate.
The following articles in journals at HighWire Press have cited this article:
![]() |
W. J. Cain, J. S. Millar, A. S. Himebauch, U. J. F. Tietge, C. Maugeais, D. Usher, and D. J. Rader Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a] J. Lipid Res., December 1, 2005; 46(12): 2681 - 2691. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Edelstein, K. Nakajima, D. Pfaffinger, and A. M. Scanu Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins J. Lipid Res., October 1, 2001; 42(10): 1664 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gonbert, B. Saint-Jore, P. Giral, C. Doucet, J. Chapman, and J. Thillet Molecular Analysis of Apo(a) Fragmentation in Polygenic Hypercholesterolemia: Characterization of a New Plasma Fragment Pattern Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1353 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. DOUCET, V. MOOSER, S. GONBERT, F. RAYMOND, J. CHAPMAN, C. JACOBS, and J. THILLET Lipoprotein(a) in the Nephrotic Syndrome: Molecular Analysis ofLipoprotein(a) and Apolipoprotein(a) Fragments in Plasma and Urine J. Am. Soc. Nephrol., March 1, 2000; 11(3): 507 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Edelstein, S. D. Shapiro, O. Klezovitch, and A. M. Scanu Macrophage Metalloelastase, MMP-12, Cleaves Human Apolipoprotein(a) in the Linker Region between Kringles IV-4 and IV-5. POTENTIAL RELEVANCE TO LIPOPROTEIN(a) BIOLOGY J. Biol. Chem., April 9, 1999; 274(15): 10019 - 10023. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mooser, F. Tinguely, P. Fontana, V. Lenain, M. Vaglio, P. Ruchat, L. K. von Segesser, S. M. Marcovina, M. Markert, R. Darioli, et al. Effect of Cardiopulmonary Bypass and Heparin on Plasma Levels of Lp(a) and Apo(a) Fragments Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 1060 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tohda, K. Oida, Y. Okada, S. Kosaka, E. Okada, S. Takahashi, H. Ishii, and I. Miyamori Expression of Thrombomodulin in Atherosclerotic Lesions and Mitogenic Activity of Recombinant Thrombomodulin in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1861 - 1869. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Edelstein, J. A. Italia, and A. M. Scanu Polymorphonuclear Cells Isolated from Human Peripheral Blood Cleave Lipoprotein(a) and Apolipoprotein(a) at Multiple Interkringle Sites via the Enzyme Elastase. GENERATION OF mini-Lp(a) PARTICLES AND apo(a) FRAGMENTS J. Biol. Chem., April 25, 1997; 272(17): 11079 - 11087. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Kostner, G. Maurer, K. Huber, T. Stefenelli, H. Dieplinger, E. Steyrer, and G. M. Kostner Urinary Excretion of Apo(a) Fragments: Role in Apo(a) Catabolism Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 905 - 911. [Abstract] [Full Text] |
||||
![]() |
B. Garner, A. H. Merry, L. Royle, D. J. Harvey, P. M. Rudd, and J. Thillet Structural Elucidation of the N- and O-Glycans of Human Apolipoprotein(a). ROLE OF O-GLYCANS IN CONFERRING PROTEASE RESISTANCE J. Biol. Chem., June 15, 2001; 276(25): 22200 - 22208. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |